ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Clinical Microbiology
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1579916
This article is part of the Research TopicPerspectives in Clinical Microbiology for Combating Multi-drug Resistant Bacterial Infections: 2024/2025View all 9 articles
Imidazolium salts carrying two positive charges: Design, synthesis, characterization, molecular docking, antibacterial and enzyme inhibitory activities
Provisionally accepted- 1Harran University, Şanlıurfa, Şanlıurfa, Türkiye
- 2Medical School, Adiyaman University, Adıyaman, Adıyaman, Türkiye
- 3Faculty of Medicine, Istanbul University, Istanbul, Istanbul, Türkiye
- 4İnönü University, Malatya, Malatya, Türkiye
- 5Bilecik Sevh Edebali University, Bilecik/Turkiye, Türkiye
- 6Vignan's Foundation for Science, Technology and Research, Guntur, India
- 7Majmaah University, Al Majma'ah, Riyadh, Saudi Arabia
- 8National Research Centre (Egypt), Cairo, Cairo, Egypt
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The discovery of alternative drugs has gained importance due to the many side effects of these drugs used for treatment. Herein, the synthesis of a series of unsymmetrical imidazolium salts containing 4acetylphenyl/4-formylphenyl and bioactive heterocyclic groups such as morpholine, piperidine, pyrrole or pyridine was reported. 4-(1-H-imidazol-1-yl)acetophenone and 4-(1-H-imidazol-1yl)benzaldehyde were used as salt precursors. Alkyl halides containing heterocyclic groups such as 2morpholinoethyl hydrochloride, 2-pyrrolidinoethyl hydrochloride, 2-piperidinoethyl hydrochloride and pyridin-2-ylmethyl bromide hydrobromide were used. Thus, there are two positively charged nitrogens in the structure of these salts synthesized by the quaternization method. The structures of all salts were fully characterized by 1 H, 13 C NMR, FTIR spectroscopic and elemental analysis methods.the a series of imidazolium salts (1a-d and 2a-d) were designed, synthesized and fully characterized by spectroscopic methods. The inhibitory effect against AChE of the series compounds was evaluated as in vitro and in silico studies. The results indicated that the compounds showed remarkably potent inhibitory effects on AChE with KI values ranging from 0.63 ± 0.04 M to 11.23 ± 1.05 M and IC50 values spanning from 0.82 ± 0.06 M to 14.75 ± 0.82 M. The antimicrobial activities of the synthesised compounds were measured by inhibition of bacterial growth expressed as minimum inhibitory concentration (MIC) values. It was observed that the synthesised compounds exhibited antimicrobial activity especially against Gram negative bacteria. In addition, the results of molecular docking studies of bacteria supported our antimicrobial results. In conclusion, the synthesized compounds showed the potential to be antimicrobial and acetylcholinesterase inhibitors.
Keywords: N-heterocyclic carbene, Imidazolium salt, Acetylcholinesterase, antimicrobial, Anti-Alzheimer
Received: 19 Feb 2025; Accepted: 23 Jun 2025.
Copyright: © 2025 Demirhan, Necip, Oner, Gumuscu, Demirci, Gok, Doni, Isik, Rudrapal, Khan and Ibrahim. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Mithun Rudrapal, Vignan's Foundation for Science, Technology and Research, Guntur, India
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.